Home/Filings/4/0001437749-21-026229
4//SEC Filing

Pascoe Richard W 4

Accession 0001437749-21-026229

CIK 0001434647other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 9:26 PM ET

Size

6.2 KB

Accession

0001437749-21-026229

Insider Transaction Report

Form 4
Period: 2021-11-10
Transactions
  • Award

    Stock Option (right to buy)

    2021-11-10+100,000100,000 total
    Exercise: $9.10Exp: 2031-11-09Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan").
  • [F2]50% of the shares will vest in four equal annual installments beginning on November 10, 2022, subject to Reporting Person's continued service as of each such vesting date; the remaining 50% of the shares will vest upon the closing of the earlier of (x) a "Change in Control" (as defined in the Plan) of the Company or (y) a transformative business development transaction, as determined in the discretion of the Board of Directors (together, the "Transactions"); provided that the definitive agreement for either of the Transactions is executed on or prior to November 10, 2022 and the Reporting Person is, immediately prior to the time of the closing of either of the Transactions, still serving as Executive Chairman or as another executive officer. All unvested outstanding time-based options granted to the Reporting Person, shall accelerate so as to be fully vested and immediately exercisable immediately prior to any Change in Control of the Company.

Issuer

KEMPHARM, INC

CIK 0001434647

Entity typeother

Related Parties

1
  • filerCIK 0001343266

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 9:26 PM ET
Size
6.2 KB